{
  "figure_1": "Treatment of locally inoperable breast cancer and application prospects of INPs. US ultrasound, MG mammography, MRI magnetic resonance imaging, PET-CT positron emission tomography-computed tomography, PAI photoacoustic imaging, FI fluorescence imaging, SERS surface-enhanced Raman scattering, CR complete response, PR partial response, SD stable disease, PD progressive disease, BCS breast-conserving surgery, ALND axillary lymph node dissection, PTT photothermal therapy, PDT photodynamic therapy, MHT magnetic hyperthermia therapy, SDT sonodynamic therapy",
  "figure_2": "Bibliometric analysis of INPs applied in breast cancer. A Annual and cumulative trend of publication from 2006 to 2023; B world map of global overview and international collaboration; C 15 clusters of key hotspots divided by CiteSpace software. Distinct clusters are color-coded for identification; D a timeline visualization of 15 clusters generated by CiteSpace software; E keyword co-occurrence analysis map produced by VOSviewer and Pajek. Nanoparticle’’s image is adapted with permission from Ref. [33–47], copyright 2019 Journal of Materials Chemistry B, 2020 International Journal of Nanomedicine, 2022 Proceedings of The National Academy of Sciences of the United States of America, 2022 International Journal of Molecular Sciences, 2019 Science Advances, 2017 Nanomedicine, 2020 Acs Applied Materials & Interfaces, 2020 Talanta, 2021 Analytical And Bioanalytical Chemistry, 2018 Science Advances, 2019 Nano Letters, 2018 Acta Biomaterialia, 2020 Journal of Materials Chemistry B; 2018 Theranostics, 2023 Angewandte Chemie-International Edition",
  "figure_3": "A summary of SPIONs available for MRI in breast cancer diagnosis. A DOX@MMSN-SS-PEI-cit nanoplatforms; B BRBP1-SPIO@mPEG (DiR) nanoparticles; C PMMA/Fe3O4/PAA Jnps; D. CREKA-modified iron oxide (IO) NPs; E DOX-QD-NPs. A Is adapted with permission from [50], copyright 2020 Journal of Colloid and Interface Science. B Is adapted with permission from [72], copyright 2020 Materials Science and Engineering: C. C Is adapted with permission from [51], copyright 2020 Biomaterials Science. D Is adapted with permission from [43], copyright 2019 Nano letters. E Is adapted with permission from [52], copyright 2020 International Journal of Pharmaceutics",
  "figure_4": "INPs for the diagnosis of breast cancer. A TUG; B Ag2TeQDs; C SWNHs/C18PMH/mPEG-PLA-DOX-Pt; D bMSN@T2-RGD-Acrk; E AuNS; F biosensor that combined CA153, CA125 and CEA antibodies with DTNB, 4MBA, and 2NAT labeled Ag nanomaterials. A Is adapted with permission from [53], copyright 2020 Journal of Materials Chemistry B. B Is adapted with permission from [39], copyright 2020 ACS Applied Materials & Interfaces. C Is adapted with permission from [46], copyright 2018 Theranostics. D Is adapted with permission from [86], copyright 2019 Nanomedicine. E Is adapted with permission from [62], copyright 2018 nanoscale. F Is adapted with permission from [92], copyright 2018 Talanta",
  "figure_5": "INPs used in breast cancer radiotherapy. A BiGdO3-PEG NPs; B PMAO-KI NPs. A Is adapted with permission from [135], copyright 2019 Physics in Medicine & Biology. B Is adapted with permission from [144], copyright 2021 ACS Nano",
  "figure_6": "INPs used in breast cancer phototherapy. A, B The application in photothermal therapy: A cmHSP-AuNC; B CuS@BSA-NB2. C, D The application in photodynamic therapy: C MD@HBF; D IrO2-GOx@HA NPs. A Is adapted with permission from [161], copyright 2021 International Journal of Pharmaceutics. B Is adapted with permission from [178], copyright 2022 Frontiers in Pharmacology. Panel C Is adapted with permission from [200], copyright 2023 Colloids and Surfaces B: Biointerfaces. D Is adapted with permission from [205], copyright 2022 Journal of Colloid and Interface Science",
  "figure_7": "INPs used in breast cancer MHT. A FA-Gel/FeNP; B DM-ACMSs. A Is adapted with permission from [218], copyright 2023 Advanced Healthcare Materials. B Is adapted with permission from [221], copyright 2018 Journal of Materials Chemistry B",
  "figure_8": "INPs used in breast cancer SDT. A AuNRsALG; B SnSNPs@PEG. A Is adapted with permission from [228], copyright 2023 Ultrasonics Sonochemistry. B Is adapted with permission from [233], copyright 2023 Nature Communications",
  "figure_9": "INPs for the local theranostic application of LABC. A M-MSN/HA/DI; B Fe3O4–Aushell–PEG160 NPs; C Fe3O4–Pd JNPs. A Is adapted with permission from [235], copyright 2020 Expert Opinion on Drug Delivery. B Is adapted with permission from [241], copyright 2021 International Journal of Nanomedicine. C Is adapted with permission from [244], copyright 2019 Nanoscale Horizons"
}